Alexandre Avrameas

Molecular and Cellular Sciences Biomarker Biomarker Expert

Greater Mulhouse Area

About

Experience

  • Novartis (Basel, Basel, Switzerland)
    • Molecular and Cellular Sciences Biomarker Biomarker Expert
      Jul 2015 - Present · 11 yrs 1 mo

      -Leading soluble and cellular biomarker identification by developing and implementing efficient, high valued technologies and suitable methods in data analysis, assay development and quantification in selected External Service Provider (ESP) / Clinical Research Organization (CRO) - Developing personalized medicine biomarker strategy for macromolecules therapies using combination of autoantibodies and biomarker profiling approaches - Team leader and/or team member/ Biomarker expert in clinical teams to establish biomarker strategies in clinical studies - Support Novartis drug development by providing scientific validated data relevant for pre-clinical and clinical studies -Contribute to the scientific and overall BMD strategies and goals and oversee execution in immunoassay biomarker group -Expertise in immuno-assay and ligand-binding assay

    • Biomarker immunoassay Head
      Oct 2006 - Jul 2015 · 8 yrs 10 mos

      Head of the Immunoassay Biomarker group in Novartis Institute Biomedical Research (NIBR)- Basel - Developing personalized medicine strategy for macromolecules therapies using combination of autoantibodies and biomarker profiling approaches - Development and validation of various biomarkers immunoassays to support clinical samples analysis - Team leader and/or team member of clinical teams to establish biomarker strategies in clinical studies - Team management includes 4 lab heads and 15 technicians divided in Basel; Cambridge and Shanghai (China) sites

  • Head of the Biomarkers (Immunoanalysis/HPLC) Unit at SGS-Cephac
    Apr 2003 - Sep 2006 · 3 yrs 6 mos

    - Development and validation of various immunoassays: RIA, ELISA, Luminescent EIA - Set-up quality control reinforced by elaboration of procedures - Establishment of development and validation study protocols of the company - Client support for developing immunoassays - Team management includes 4 study directors and 12 technicians

  • Head of Technology Development Department at Diatos
    1999 - 2002 · 3 yrs

    - Set-up quality control reinforced by elaboration of procedures - Drafting study protocols and designed patents of the company - Establishment of drugs portfolio (anti-cancer molecules or antibacterial agent) coupled with various peptide vectors in vitro and in vivo experiments using cellular biology and bioanalysis technologies - Transverse project team leader concerning other departments : co-ordination of speakers, experiments distribution, included in other transverse projects as team member - Team management includes one researcher, two research engineers, two technicians and recruitment participation of personnel for research projects